Artykuły w czasopismach na temat „Cancer ratio”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Cancer ratio”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Atchyuta, M., I. V. Renuka, P. Premalatha, PAV Krishnamacharyulu, Chitturi Ramya, and U. Pravallika. "Lymphnodal Ratio in Prognostication of Stage III Colon Cancer." Indian Journal of Pathology: Research and Practice 8, no. 2 (2019): 153–58. http://dx.doi.org/10.21088/ijprp.2278.148x.8219.4.
Pełny tekst źródłaVerma, Akash, Rucha S. Dagaonkar, Dominic Marshall, John Abisheganaden, and R. W. Light. "Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)." Canadian Respiratory Journal 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/7348239.
Pełny tekst źródłaEruku, Dr Baburao. "Differentiating malignant effusions from other exudative effusions by cancer ratio and cancer ratio plus." International Journal of Advanced Research in Medicine 3, no. 2 (2021): 525–29. http://dx.doi.org/10.22271/27069567.2021.v3.i2h.453.
Pełny tekst źródłaEllis, Libby, Aurélien Belot, Bernard Rachet, and Michel P. Coleman. "The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival." Journal of Global Oncology, no. 5 (December 2019): 1–9. http://dx.doi.org/10.1200/jgo.19.00038.
Pełny tekst źródłaAbhinav, Manish, Garg Nita, and Sharma Narotam. "Serum CA125, CEA, CA125/CEA ratio and LDH levels in Ovarian Cancer." Indian Journal of Genetics and Molecular Research 7, no. 1 (2018): 17–20. http://dx.doi.org/10.21088/ijgmr.2319.4782.7118.3.
Pełny tekst źródłaFujisawa, Daisuke, Shino Umezawa, Maiko Fujimori, and Mitsunori Miyashita. "Prevalence and associated factors of perceived cancer-related stigma in Japanese cancer survivors." Japanese Journal of Clinical Oncology 50, no. 11 (2020): 1325–29. http://dx.doi.org/10.1093/jjco/hyaa135.
Pełny tekst źródłaP. G., Naveen, and K. Veena L. Karanth. "Derived neutrophil by lymphocytes ratio is a misnomer, implication of derived leucocytes ratio in diagnosing gastric cancers." International Surgery Journal 6, no. 1 (2018): 82. http://dx.doi.org/10.18203/2349-2902.isj20185187.
Pełny tekst źródłaKim, Sunsuk, Moon Kyung Joo, Jong-Jae Park, et al. "Neutrophil-to-lymphocyte ratio to predict metachronous cancer after curative resection of early gastric cancer." Journal of Clinical Oncology 42, no. 3_suppl (2024): 313. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.313.
Pełny tekst źródłaGawiński, Cieszymierz, Andrzej Mróz, Katarzyna Roszkowska-Purska, et al. "A Prospective Study on the Roles of the Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer." Biomedicines 11, no. 11 (2023): 3048. http://dx.doi.org/10.3390/biomedicines11113048.
Pełny tekst źródłaYasuda, Koji. "The correlation of neutrophil/lymphocyte ratio and tumor reduction ratio in preoperative chermoradiotherapy for advanced rectal cancer." Journal of Clinical Oncology 32, no. 3_suppl (2014): 633. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.633.
Pełny tekst źródłaInternational, Journal of Medical Science and Innovative Research (IJMSIR). "A Cross Sectional Study to Determine The Efficacy of Serum LDH: Pleural Fluid Ada Ratio As A Biomarker of Malignant Pleural Effusion in IRD, SMS Medical College, Jaipur." International Journal of Medical Science and Innovative Research (IJMSIR) 9, no. 4 (2024): 151–58. https://doi.org/10.5281/zenodo.15422923.
Pełny tekst źródłaYazici, Pinar, Mehmet Mihmanli, Emre Bozkurt, Feyza Ozturk, and Mehmet Uludag. "Which is the best predictor of thyroid cancer: thyrotropin, thyroglobulin or their ratio?" HORMONES 15, no. 2 (2016): 256–63. http://dx.doi.org/10.14310/horm.2002.1677.
Pełny tekst źródłaAri, Aziz, and Feray Gunver. "Comparison of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in patients with thyroiditis and papillary tumors." Journal of International Medical Research 47, no. 5 (2019): 2077–83. http://dx.doi.org/10.1177/0300060519838392.
Pełny tekst źródłaGawiński, Cieszymierz, Anna Hołdakowska, and Lucjan Wyrwicz. "Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Extramural Vascular Invasion (EMVI) in Locally Advanced Rectal Cancer." Current Oncology 30, no. 1 (2022): 545–58. http://dx.doi.org/10.3390/curroncol30010043.
Pełny tekst źródłaRosa, Fausto, Antonio Pio Tortorelli, Sergio Alfieri, and Giovanni Battista Doglietto. "Lymph Node Ratio for Gastric Cancer." Annals of Surgery 259, no. 4 (2014): e65. http://dx.doi.org/10.1097/sla.0000000000000316.
Pełny tekst źródłaGawiński, Cieszymierz. "Reproducibility of lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with locally advanced rectal cancer." Journal of Clinical Oncology 40, no. 4_suppl (2022): 166. http://dx.doi.org/10.1200/jco.2022.40.4_suppl.166.
Pełny tekst źródłaWang, Jeanny, Eric Engels, and Minkyo Song. "Abstract 2250: Eosinophil-to-lymphocyte ratio and cancer risk in the UK Biobank." Cancer Research 82, no. 12_Supplement (2022): 2250. http://dx.doi.org/10.1158/1538-7445.am2022-2250.
Pełny tekst źródłaBahgat, Taha. "Breast cancer prognostication with neutrophil–lymphocyte ratio and platelet–lymphocyte ratio." Al-Azhar Assiut Medical Journal 15, no. 4 (2017): 179. http://dx.doi.org/10.4103/azmj.azmj_45_16.
Pełny tekst źródłaLópez Altamirano, Joselyn Macarena, and Daniela Alexandra Rosero Freire. "Prognostic efficacy of platelet/lymphocyte ratio and neutrophil/lymphocyte ratio in patients with gastric cancer." Salud, Ciencia y Tecnología 3 (January 26, 2023): 232. http://dx.doi.org/10.56294/saludcyt2023232.
Pełny tekst źródłaFIRAT, Sevde Nur, Işılay TAŞKALDIRAN, Şerife KUŞKONMAZ, and Cavit ÇULHA. "AST/ALT (De Ritis) Ratio in Early Stage Differentiated Thyroid Cancer." Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 8, no. 2 (2022): 125–28. http://dx.doi.org/10.30934/kusbed.1009993.
Pełny tekst źródłaKumarasamy, Chellan, Vaibhav Tiwary, Krishnan Sunil, et al. "Prognostic Utility of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio and Monocyte–Lymphocyte Ratio in Head and Neck Cancers: A Detailed PRISMA Compliant Systematic Review and Meta-Analysis." Cancers 13, no. 16 (2021): 4166. http://dx.doi.org/10.3390/cancers13164166.
Pełny tekst źródłaWiranata, Sinta, Ida Ayu Widya Anjani, I. Putu Gede Septiawan Saputra, et al. "Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as a Stage Determination in Breast Cancer." Open Access Macedonian Journal of Medical Sciences 8, B (2020): 1058–63. http://dx.doi.org/10.3889/oamjms.2020.5336.
Pełny tekst źródłaBudiana, Budian, Bayu Mahendra, Putra Wiradnyana, Darmayasa Darmayasa, Fajar Marta, and Suwanpramana Suwanpramana. "C-Reactive Protein/Albumin (Crp/Alb) Ratio as a Predictor of Ovarian Cancer." Jurnal Health Sains 4, no. 5 (2023): 79–90. http://dx.doi.org/10.46799/jhs.v4i5.913.
Pełny tekst źródłaEcin, Seval Müzeyyen, and Deniz Gezer. "Evaluation of the clinical and prognostic importance of infection parameters in thyroid cancers: A cross-sectional study." Medicine 102, no. 49 (2023): e36532. http://dx.doi.org/10.1097/md.0000000000036532.
Pełny tekst źródłaSubhankar Saren, Animesh Mandal, Amit Kumar Das, Ranjit Kumar Haldar, and Sudipta Pandit. "Identifying malignant pleural effusion from tubercular pleural effusion by study of cancer ratio and cancer ratio plus." Asian Journal of Medical Sciences 16, no. 2 (2025): 97–102. https://doi.org/10.71152/ajms.v16i2.4323.
Pełny tekst źródłaAsif, Aqua, Vinson Wai-Shun Chan, Filzah Hanis Osman, et al. "The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Small Renal Cell Carcinomas after Image-Guided Cryoablation or Radio-Frequency Ablation." Cancers 15, no. 7 (2023): 2187. http://dx.doi.org/10.3390/cancers15072187.
Pełny tekst źródłaZhang, Yu, Le Wang, Yunduo Liu, et al. "Preoperative Neutrophil-Lymphocyte Ratio Before Platelet-Lymphocyte Ratio Predicts Clinical Outcome in Patients With Cervical Cancer Treated With Initial Radical Surgery." International Journal of Gynecologic Cancer 24, no. 7 (2014): 1319–25. http://dx.doi.org/10.1097/igc.0000000000000219.
Pełny tekst źródłaTurchan, William Tyler, Sean P. Pitroda, and Ralph R. Weichselbaum. "Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy." Neoplasia 27 (May 2022): 100782. http://dx.doi.org/10.1016/j.neo.2022.100782.
Pełny tekst źródłaGupta, Dr Ashumi, Dr Urvashi Singh, Dr Mohan Lal Gupta, Dr Narendra Mogra, and Dr Medha Mathur. "Significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in lung cancer." Tropical Journal of Pathology and Microbiology 5, no. 11 (2019): 872–77. http://dx.doi.org/10.17511/jopm.2019.i11.07.
Pełny tekst źródłaKartolo, Adi, Ryan Holstead, Sidra Khalid, et al. "Serum neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in prognosticating immunotherapy efficacy." Immunotherapy 12, no. 11 (2020): 785–98. http://dx.doi.org/10.2217/imt-2020-0105.
Pełny tekst źródłaBeyhan Sagmen, Seda, Coskun Dogan, Sevda Comert, Nesrin Kiral, Ali Fidan, and Elif Torun Parmaksiz. "Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Lung Cancer." Medical Laboratory Technology Journal 5, no. 1 (2019): 32. http://dx.doi.org/10.31964/mltj.v5i1.211.
Pełny tekst źródłaLee, Yen-Chien, Yen-Ling Lee, and Chung-Yi Li. "BRCA Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies." Medicina 57, no. 9 (2021): 905. http://dx.doi.org/10.3390/medicina57090905.
Pełny tekst źródłaTran, Thi-Van-Trinh, Cari M. Kitahara, Florent de Vathaire, Marie-Christine Boutron-Ruault, and Neige Journy. "Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis." Endocrine-Related Cancer 27, no. 4 (2020): 245–59. http://dx.doi.org/10.1530/erc-19-0417.
Pełny tekst źródłaNguyen, Mai Ly Thi, Chi Pham, Quoc Vuong Le, et al. "The diagnostic and prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on gastric cancer patients." Medicine 102, no. 31 (2023): e34357. http://dx.doi.org/10.1097/md.0000000000034357.
Pełny tekst źródłaAthanasiou, Antonios, Michael Spartalis, and Eleftherios Spartalis. "Platelets-to-lymphocyte ratio and esophageal cancer." Journal of Thoracic Disease 10, no. 8 (2018): E650—E651. http://dx.doi.org/10.21037/jtd.2018.07.41.
Pełny tekst źródłaVergote, Ignace B., Peter A. van Dam, Gert M. Laekeman, Guy H. Keersmaeckers, Frans L. Uyttenbroeck, and Arnold G. Herman. "Prostacyclin/Thromboxane Ratio in Human Breast Cancer." Tumor Biology 12, no. 5 (1991): 261–66. http://dx.doi.org/10.1159/000217713.
Pełny tekst źródłaClifford, Gary M., Mauro Lise, Silvia Franceschi, and Alexandra U. Scherrer. "CD4/CD8 ratio and lung cancer risk." Lancet HIV 4, no. 3 (2017): e103. http://dx.doi.org/10.1016/s2352-3018(17)30027-9.
Pełny tekst źródłaRaza, Syed Ahsan, Ramzan tahir, Mirelle Schnitzer, and Jack Siemiatycki. "Worldwide Sex Ratio Variations in Cancer Incidence." Annals of Epidemiology 27, no. 8 (2017): 507–8. http://dx.doi.org/10.1016/j.annepidem.2017.07.113.
Pełny tekst źródłaOng, Hui Shan, Sandhya Gokavarapu, Li Zhen Wang, Zhen Tian, and Chen Ping Zhang. "Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer." Journal of Oral and Maxillofacial Surgery 75, no. 8 (2017): 1762–74. http://dx.doi.org/10.1016/j.joms.2016.12.023.
Pełny tekst źródłaMatuszczak, Milena, Adam Kiljańczyk, Wojciech Marciniak, et al. "Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers." Antioxidants 13, no. 7 (2024): 841. http://dx.doi.org/10.3390/antiox13070841.
Pełny tekst źródłaMosalem, Osama, Saud Alsubait, Shouq Kherallah, et al. "Impact of pre-treatment lymphocyte monocyte ratio and neutrophil lymphocyte ratio on pathologic response in breast cancer patients receiving neoadjuvant chemotherapy." Journal of Clinical Oncology 39, no. 15_suppl (2021): e12623-e12623. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e12623.
Pełny tekst źródłaZhu, Xuming, Huizhu Song, Yan Chen, Feifei Han, Qiong Wang, and Yubao Cui. "Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Blood to Distinguish Lung Cancer Patients from Healthy Subjects." Disease Markers 2020 (October 16, 2020): 1–5. http://dx.doi.org/10.1155/2020/8844698.
Pełny tekst źródłaPyo, Jung-Soo, Young-Min Shin, and Dong-Wook Kang. "Prognostic Implication of Metastatic Lymph Node Ratio in Colorectal Cancers: Comparison Depending on Tumor Location." Journal of Clinical Medicine 8, no. 11 (2019): 1812. http://dx.doi.org/10.3390/jcm8111812.
Pełny tekst źródłaGawiński, Cieszymierz, Mariola Winiarek, Sebastian Rybski, Maciej Temnyk, Katarzyna Kokoszyńska, and Lucjan Wyrwicz. "Reproducibility of pretreatment lymphocyte-to-monocyte ratio (LMR) in rectal cancer." Journal of Clinical Oncology 36, no. 4_suppl (2018): 715. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.715.
Pełny tekst źródłaMing, Xinliang, Shili Qiu, Xuefang Liu, et al. "Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis." Technology in Cancer Research & Treatment 18 (January 1, 2019): 153303381882110. http://dx.doi.org/10.1177/1533033818821106.
Pełny tekst źródłaMezzanotte, Guerrino, Cesare Cislaghi, Adriano Decarli, and Carlo La Vecchia. "Cancer Mortality in Broad Italian Geographical Areas, 1975-1977." Tumori Journal 72, no. 2 (1986): 145–52. http://dx.doi.org/10.1177/030089168607200205.
Pełny tekst źródłaLee, Suee, Sung Yong Oh, Hyuk-Chan Kwon, et al. "The clinical significance of neutrophil-lymphocyte ratio versus platelet-lymphocyte ratio in patients with metastatic gastric cancer." Journal of Clinical Oncology 30, no. 15_suppl (2012): e14686-e14686. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e14686.
Pełny tekst źródłaGoldacre, Michael J., Lianne M. Kurina, Clare J. Wotton, David Yeates, and Valerie Seagroatt. "Schizophrenia and cancer: an epidemiological study." British Journal of Psychiatry 187, no. 4 (2005): 334–38. http://dx.doi.org/10.1192/bjp.187.4.334.
Pełny tekst źródłaHechter, Sharon, Ivan Nikiforov, and David B. Greenberg. "Gastrointestinal cancer trends in the Hispanic population: A SEER database population study (2000-2019)." Journal of Clinical Oncology 41, no. 16_suppl (2023): e16331-e16331. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e16331.
Pełny tekst źródłaHechter, Sharon, Ivan Nikiforov, and David B. Greenberg. "Gastrointestinal cancer trends in the Hispanic population: A SEER database population study (2000-2019)." Journal of Clinical Oncology 42, no. 3_suppl (2024): 725. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.725.
Pełny tekst źródła